Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA accepts Prevail's IND for phase I/II study of PR-001 for Parkinson's disease with GBA1 mutation

June 5, 2019

FDA approves Emgality for episodic cluster headache

June 5, 2019

Oncolytic virus works in pediatric brain tumors

June 5, 2019

Cellenkos initiates phase I trial of CK-0801 for bone marrow failure syndromes

June 5, 2019

Safety results from CITN-12 study on pembrolizumab in patients with HIV and cancer

June 5, 2019

Teligene discloses Bruton tyrosine kinase and/or HER2 inhibitors

June 5, 2019

New slective estrogen receptor degraders identified at Anlin Pharmaceuticals

June 5, 2019

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent anti-HBV compounds

June 5, 2019

Bayer and The Broad Institute synthesize Mcl-1 inhibitors

June 5, 2019

Arcutis begins phase IIa trial of ARQ-151 in atopic dermatitis

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...